In May 2016 we were happy to host Qumra Capital’s first Annual Meeting in Tel Aviv, Israel. Our Limited Partners and portfolio companies enjoyed the opportunity to meet and share perspectives with a special appearance of the wonderful Ninet Tayeb and Shlomi Shaban
Signals Analytics Announces a COVID-19 Playbook Leveraging Advanced Analytics for Accelerating Vaccine Development and Drug Discovery
Signals Analytics, the next-generation advanced analytics platform that leverages external data to uncover trends and predictive insights, today unveils its COVID-19 Playbook, providing access to critical market intelligence and trends surrounding potential treatments for the novel coronavirus. As part of their dedication to fighting the virus, Signals Analytics is offering the COVID-19 Playbook at no cost to researchers looking to monitor vaccines that are in development for COVID-19 and other strains of coronavirus; monitor trending drugs that are being tested for COVID-19; and assess which drugs are being repurposed to help treat infected people.